PUBLICATIONS · 16648504
Open-label, multicenter, randomized, phase III study comparing oral topotecan/cisplatin versus etoposide/cisplatin as treatment for chemotherapy-naive patients with extensive-disease small-cell lung cancer.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- J Clin Oncol
- Publication date
- 2006 May 1
- First author
- Eckardt JR
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- citation
- J Clin Oncol. 2006 May 1;24(13):1980-1. doi: 10.1200/JCO.2006.05.6788.
- note
- Source null
- related pmid
- 16648497
- relationship
- Comment in
Authors and identifiers
- name
- Eckardt JR
- type
- Author
- name
- von Pawel J
- type
- Author
- name
- Papai Z
- type
- Author
- name
- Tomova A
- type
- Author
- name
- Tzekova V
- type
- Author
- name
- Crofts TE
- type
- Author
- name
- Brannon S
- type
- Author
- name
- Wissel P
- type
- Author
- name
- Ross G
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Eckardt JR
- type
- Author
- name
- von Pawel J
- type
- Author
- name
- Papai Z
- type
- Author
- name
- Tomova A
- type
- Author
- name
- Tzekova V
- type
- Author
- name
- Crofts TE
- type
- Author
- name
- Brannon S
- type
- Author
- name
- Wissel P
- type
- Author
- name
- Ross G
- type
- Author
- bibliography ids
- nci-bib-efb80653005fcb350fae5afb
- book metadata
- content sha256
- d87e8f2fa45719cb781cef9b3c88a47326bbbd7d9147f6fd2596d25ae4d6026c
- document type
- citation
- dois
- 10.1200/JCO.2005.03.3332
- electronic publication date
- display
- Source null
- precision
- missing
- year
- Source null
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:16648504
- immutable id
- pubmed:16648504@d87e8f2fa45719cb781cef9b3c88a47326bbbd7d9147f6fd2596d25ae4d6026c
- journal
- abbreviation
- J Clin Oncol
- issn electronic
- 1527-7755
- issn print
- 0732-183X
- issue
- 13
- name
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology
- nlm unique id
- 8309333
- pages
- 2044-51
- volume
- 24
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- citation
- J Clin Oncol. 2006 May 1;24(13):1980-1. doi: 10.1200/JCO.2006.05.6788.
- note
- Source null
- related pmid
- 16648497
- relationship
- Comment in
- outcomes validated
- false
- pmid
- 16648504
- provenance
- batch id
- 19fb2de9a00882c94e86
- provider
- NCBI PubMed ESummary
- record sha256
- 9e57113a98b77e9c6f503d167309862c32198190114617d9e28ed39f69dab0a9
- response sha256
- 4c446464d8fd06bff771a2bb5f3529ef4abe372e3c19f6fb7223068d839a263d
- retrieved at
- 2026-09-09T23:46:06.810486+00:00
- publication date
- display
- 2006 May 1
- precision
- day
- year
- 2006
- publication types
- Clinical Trial, Phase III
- Journal Article
- Multicenter Study
- Randomized Controlled Trial
- Research Support, Non-U.S. Gov't
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Open-label, multicenter, randomized, phase III study comparing oral topotecan/cisplatin versus etoposide/cisplatin as treatment for chemotherapy-naive patients with extensive-disease small-cell lung cancer.
Preserved source evidence · Not medical advice
Triangle